Healthcare Sector Analytics

Market size, company revenue, drug approvals, clinical trials, regulation, hospitals, doctors, drug spending, labs and devices

SFDARegulator guidanceDossier formatMedicinesHigh confidenceLast verified October 3, 2026

DS-REQ-002

Data Requirements for Human Drugs Submission: Content of the Dossier

Current edition

Version 4.0 of August 3, 2025

About this standard

Content of Modules 1 to 5 of the registration dossier for new chemical entities, biologicals, biosimilars and generic products.

Recognition by market

Whether the market recognizes, harmonizes or adopts this standard, and which edition it accepts

No market listing is published yet.

Testing requirements that cite it

Open the market page and its pathway pages for the full requirement, protocol and report content

Related standards: FDA eCTD submission guidance, MDR 2017 Fourth Schedule, Appendix II and III, JP notification on electronic study data (2024), M4(R4), M4Q(R1), M4Q(R2), M4S(R2), M4E(R2), ACTD, CDSCO Guidance for Industry (Biologicals), COFEPRIS CTD guide v3.0, DS-G-003. See all standards.

Not legal or regulatory advice. Check the current official rules before you act. Parts of the approvals data are official open data reused under open licences. Data sources.

LinkedInLinkedInXXYouTubeYouTube